表紙
市場調査レポート

Radius Health, Inc. - 製品パイプライン分析

Radius Health, Inc. - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 253807
出版日 ページ情報 英文 29 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.39円で換算しております。
Back to Top
Radius Health, Inc. - 製品パイプライン分析 Radius Health, Inc. - Product Pipeline Review - 2014
出版日: 2014年08月14日 ページ情報: 英文 29 Pages
概要

Radius Health, Inc. は、骨祖しょう症や婦人科系疾患に対する新世代の治療薬の発見と開発に取り組む製薬・医療会社であり、主に代謝性骨疾患や生殖障害治療のための薬剤開発を行っています。

当レポートでは、USV Limitedにおける治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

Radius Health, Inc.の基本情報

Radius Health, Inc.の概要

  • 主要情報
  • 企業情報

Radius Health, Inc.:R&Dの概要

  • 主な治療範囲

Radius Health, Inc.:パイプラインレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

Radius Health, Inc.:パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 第III相にある製品/併用療法モダリティ
  • 治験段階にあるパイプライン製品
    • 第II相にある製品/併用療法モダリティ
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床段階にある製品/併用療法モダリティ

Radius Health, Inc.:薬剤プロファイル

  • abaloparatide
  • RAD-1901
  • RAD-140

Radius Health, Inc.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Radius Health, Inc.:最近のパイプライン動向

Radius Health, Inc.:本社と子会社の所在地

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC06157CDB

Summary

Global Markets Direct's, 'Radius Health, Inc. - Product Pipeline Review - 2014', provides an overview of the Radius Health, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Radius Health, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Radius Health, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Radius Health, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Radius Health, Inc.'s pipeline products

Reasons to buy

  • Evaluate Radius Health, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Radius Health, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Radius Health, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Radius Health, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Radius Health, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Radius Health, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Radius Health, Inc. Snapshot
    • Radius Health, Inc. Overview
    • Key Information
    • Key Facts
  • Radius Health, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Radius Health, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Radius Health, Inc. - Pipeline Products Glance
    • Radius Health, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Radius Health, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Radius Health, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Radius Health, Inc. - Drug Profiles
    • abaloparatide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RAD-1901
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • RAD-140
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Radius Health, Inc. - Pipeline Analysis
    • Radius Health, Inc. - Pipeline Products by Target
    • Radius Health, Inc. - Pipeline Products by Route of Administration
    • Radius Health, Inc. - Pipeline Products by Molecule Type
    • Radius Health, Inc. - Pipeline Products by Mechanism of Action
  • Radius Health, Inc. - Recent Pipeline Updates
  • Radius Health, Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Radius Health, Inc., Key Information
  • Radius Health, Inc., Key Facts
  • Radius Health, Inc. - Pipeline by Indication, 2014
  • Radius Health, Inc. - Pipeline by Stage of Development, 2014
  • Radius Health, Inc. - Monotherapy Products in Pipeline, 2014
  • Radius Health, Inc. - Partnered Products in Pipeline, 2014
  • Radius Health, Inc. - Partnered Products/ Combination Treatment Modalities, 2014
  • Radius Health, Inc. - Phase III, 2014
  • Radius Health, Inc. - Phase II, 2014
  • Radius Health, Inc. - Phase I, 2014
  • Radius Health, Inc. - Preclinical, 2014
  • Radius Health, Inc. - Pipeline by Target, 2014
  • Radius Health, Inc. - Pipeline by Route of Administration, 2014
  • Radius Health, Inc. - Pipeline by Molecule Type, 2014
  • Radius Health, Inc. - Pipeline Products by Mechanism of Action, 2014
  • Radius Health, Inc. - Recent Pipeline Updates, 2014

List of Figures

  • Radius Health, Inc. - Pipeline by Top 10 Indication, 2014
  • Radius Health, Inc. - Pipeline by Stage of Development, 2014
  • Radius Health, Inc. - Monotherapy Products in Pipeline, 2014
  • Radius Health, Inc. - Partnered Products in Pipeline, 2014
  • Radius Health, Inc. - Pipeline by Top 10 Target, 2014
  • Radius Health, Inc. - Pipeline by Top 10 Route of Administration, 2014
  • Radius Health, Inc. - Pipeline by Top 10 Molecule Type, 2014
  • Radius Health, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top